No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SLS Sellas Life Sciences
- 0.888
- -0.010-1.11%
Close Dec 20 16:00 ET
- 0.950
- +0.062+6.98%
Post 19:50 ET
62.50MMarket Cap-1.33P/E (TTM)
0.930High0.870Low1.21MVolume0.910Open0.898Pre Close1.09MTurnover1.73%Turnover RatioLossP/E (Static)70.38MShares1.72052wk High3.93P/B61.99MFloat Cap0.49952wk Low--Dividend TTM69.81MShs Float554.500Historical High--Div YieldTTM6.64%Amplitude0.499Historical Low0.900Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Promising Phase 2 Results and Strategic Potential Drive Buy Rating for SELLAS Life Sciences' SLS009
Express News | Sellas Life Sciences Group: Study Reaches Pre-Specified Threshold of 60 Events (Deaths) Initiating Interim Analysis
Express News | Sellas Life Sciences Group: Regal Independent Data Monitoring Committee to Perform Interim Analysis in Jan 2025
Express News | Sellas Life Sciences Triggers Interim Analysis in Phase 3 Regal Trial of Gps in Acute Myeloid Leukemia
SELLAS Life Sciences Triggers Interim Analysis in Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
SELLAS Reports Positive Survival Data From Mid-stage Trial of Its Leukemia Treatment
Heat List
US
Overall
Symbol
Price
% Chg
No Data